Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvin S T Lim

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 3, 2016
Fluorescence In Situ Hybridization on Tissue SectionsAlvin S T Lim, Tse Hui Lim
Annals of the Academy of Medicine, Singapore|August 13, 2008
Holoprosencephaly: an antenatally-diagnosed case series and subject reviewAlvin S T Lim, Tse Hui Lim, Su Keyau Kee, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|December 2, 2014
Amplification of 1q21 and other abnormalities in multiple myeloma patients from a tertiary hospital in singaporeAlvin S T Lim, Sathish Krishnan, Tse Hui Lim, et al.
Annals of the Academy of Medicine, Singapore|October 20, 2010
Bone marrow cytogenetics workup: Application of lean management system to determine if additional cell workup is helpful and necessary to analysisAlvin S T Lim, Ting Jie Chen, Tse Hui Lim, et al.
Plos One|July 8, 2014
Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cellsBee Luan Khoo, Majid Ebrahimi Warkiani, Daniel Shao-Weng Tan, et al.
Nature Medicine|October 3, 2017
Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrenceJian Yuan Goh, Min Feng, Wenyu Wang, et al.
Histopathology|August 24, 2017
Clear cell sarcomas of the kidney are characterised by BCOR gene abnormalities, including exon 15 internal tandem duplications and BCOR-CCNB3 gene fusionMeng K Wong, Cedric C Y Ng, Chik H Kuick, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2020
Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLCAaron C Tan, Amanda O L Seet, Gillianne G Y Lai, et al.
Lung Cancer (Amsterdam, Netherlands)|December 14, 2019
Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysisAaron C Tan, Gillianne G Y Lai, Gek San Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2019
Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung CancerGillianne G Y Lai, Tse Hui Lim, John Lim, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|December 3, 2016
Fluorescence In Situ Hybridization on Tissue SectionsAlvin S T Lim, Tse Hui Lim
Annals of the Academy of Medicine, Singapore|August 13, 2008
Holoprosencephaly: an antenatally-diagnosed case series and subject reviewAlvin S T Lim, Tse Hui Lim, Su Keyau Kee, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|December 2, 2014
Amplification of 1q21 and other abnormalities in multiple myeloma patients from a tertiary hospital in singaporeAlvin S T Lim, Sathish Krishnan, Tse Hui Lim, et al.
Annals of the Academy of Medicine, Singapore|October 20, 2010
Bone marrow cytogenetics workup: Application of lean management system to determine if additional cell workup is helpful and necessary to analysisAlvin S T Lim, Ting Jie Chen, Tse Hui Lim, et al.
Plos One|July 8, 2014
Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cellsBee Luan Khoo, Majid Ebrahimi Warkiani, Daniel Shao-Weng Tan, et al.
Nature Medicine|October 3, 2017
Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrenceJian Yuan Goh, Min Feng, Wenyu Wang, et al.
Histopathology|August 24, 2017
Clear cell sarcomas of the kidney are characterised by BCOR gene abnormalities, including exon 15 internal tandem duplications and BCOR-CCNB3 gene fusionMeng K Wong, Cedric C Y Ng, Chik H Kuick, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2020
Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLCAaron C Tan, Amanda O L Seet, Gillianne G Y Lai, et al.
Lung Cancer (Amsterdam, Netherlands)|December 14, 2019
Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysisAaron C Tan, Gillianne G Y Lai, Gek San Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2019
Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung CancerGillianne G Y Lai, Tse Hui Lim, John Lim, et al.
Pageof 1